Grant: Project Grant
University of Calgary
$100,000.00
Lymph drainage dynamics in edematous condition in inflammation and cancer metastasis
EF 2016-17
Résumé
Lymphedema is a condition of uncontrolled fluid accumulation and tissue swelling. Lymphedema can cause discomfort, immobility and organ dysfunction. Edematous tissue in lymphedema is under high risk of infection. Primary lymphedema is caused by genetic defects and is relatively rare. The major cause of lymphedema in the world is lymphatic filariasis, which affects an estimated 140 million people. Another important cause of lymphedema is the damage of lymphatic vessels and LN associated with cancer and cancer therapies, which impact almost all of the cancer types that involve cancer spread via the lymphatic vessels. For instance, between 38 and 89% of breast cancer patients will eventually develop a certain stage of lymphedema. Patients are usually ignored until they exhibit significantly body disfigurement and frequent infection, the stage when they need life-long intervention with pressure garments. Lymphedema causes a huge Psycho-Social and Economic Impact on these patients. Currently, there is no cure for lymphedema. Lack of the mechanistic understanding of lymph drainage has been the barrier for the disease prevention or treatment.
Lymphatic vessels maintain fluid balance and transport tissue waste, pathogens and cells to lymph nodes (LNs) for protection by the immune system. Our study is to understand how lymph drainage is regulated in healthy and diseased states. We will determine how altered lymph drainage affects host immunity in inflammation and cancer. Our work indicates that impaired lymph drainage in the edematous condition causes immune suppression in the affected tissues, and likely causes a susceptibility to infection or a block of anti-cancer immunity. Enhancing lymph drainage can improve host immune protection or anti-tumor immunity.
Programme
Project Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
351870
Name
Liao Shan
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Lymph drainage dynamics in edematous condition in inflammation and cancer metastasis
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Antigen Delivery; Collagen; Fibroblastic Reticular Cells (Frcs); Immune Suppression; Lymph Drainage; Lymph Node (Ln); Lymph Node Conduit (Ln Conduit); Lymphatic Metastasis; Lymphedema; Tumor Draining Lymph Node (Tuln)
Abstract
Lymphedema is a condition of uncontrolled fluid accumulation and tissue swelling. Lymphedema can cause discomfort, immobility and organ dysfunction. Edematous tissue in lymphedema is under high risk of infection. Primary lymphedema is caused by genetic defects and is relatively rare. The major cause of lymphedema in the world is lymphatic filariasis, which affects an estimated 140 million people. Another important cause of lymphedema is the damage of lymphatic vessels and LN associated with cancer and cancer therapies, which impact almost all of the cancer types that involve cancer spread via the lymphatic vessels. For instance, between 38 and 89% of breast cancer patients will eventually develop a certain stage of lymphedema. Patients are usually ignored until they exhibit significantly body disfigurement and frequent infection, the stage when they need life-long intervention with pressure garments. Lymphedema causes a huge Psycho-Social and Economic Impact on these patients. Currently, there is no cure for lymphedema. Lack of the mechanistic understanding of lymph drainage has been the barrier for the disease prevention or treatment.
Lymphatic vessels maintain fluid balance and transport tissue waste, pathogens and cells to lymph nodes (LNs) for protection by the immune system. Our study is to understand how lymph drainage is regulated in healthy and diseased states. We will determine how altered lymph drainage affects host immunity in inflammation and cancer. Our work indicates that impaired lymph drainage in the edematous condition causes immune suppression in the affected tissues, and likely causes a susceptibility to infection or a block of anti-cancer immunity. Enhancing lymph drainage can improve host immune protection or anti-tumor immunity.
Competitiondate
201604
Approvedterm2
1 yr 0 mth
Pinamesdelim
Liao, Shan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~